🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Recent prospective multicenter phase II study assessed the efficacy and tol...
Status
Unknown
Location
Kosin University Gospel Hospital
Start Date
2019-03-11
Trial ID
NCT03809780
Treatments Being Tested
This research study is evaluating a new drug called "nivolumab" as a possib...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10-20
Trial ID
NCT02903381
Treatments Being Tested
Patients included in the study will receive induction treatment during 6 mo...
Status
Active Not Recruiting
Location
Hospital Clínic de Barcelona
Start Date
2015-05
Trial ID
NCT02415413
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of induction the...
Status
Completed
Location
Duke University Medical Center
Start Date
2008-08
Trial ID
NCT00691704
Treatments Being Tested
Patients with previously treated multiple myeloma and kidney dysfunction wi...
Status
Terminated
Location
Mayo Clinic in Arizona
Start Date
2009-01-21
Trial ID
NCT00790842
Treatments Being Tested
The purpose of this study is to compare the effects, good and bad, of two w...
Status
Completed
Location
Memoral Sloan Kettering Cancer Center
Start Date
2008-12-10
Trial ID
NCT00807599
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose and ef...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2008-06
Trial ID
NCT00833833
Treatments Being Tested
This phase II trial studies how well carfilzomib, lenalidomide, and dexamet...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2013-01
Trial ID
NCT01816971
The study is designed as a randomized, controlled, open-label, assessor bli...
Status
Active Not Recruiting
Location
Complejo Hospitalario Universitario A Coruña
Start Date
2018-10-22
Trial ID
NCT03742297
Treatments Being Tested
CC5013-MM024 is a multicenter, open-label, Extended Access Program (EAP) of...
Status
Completed
Location
Peking University Third Hospital
Start Date
2012-09-11
Trial ID
NCT02348528
Treatments Being Tested